Cargando…
Prostate Cancer Stem Cell-Targeted Efficacy of a New-Generation Taxoid, SBT-1214 and Novel Polyenolic Zinc-Binding Curcuminoid, CMC2.24
BACKGROUND: Prostate cancer is the second leading cause of cancer death among men. Multiple evidence suggests that a population of tumor-initiating, or cancer stem cells (CSCs) is responsible for cancer development and exceptional drug resistance, representing a highly important therapeutic target....
Autores principales: | Botchkina, Galina I., Zuniga, Edison S., Rowehl, Rebecca H., Park, Rosa, Bhalla, Rahuldev, Bialkowska, Agnieszka B., Johnson, Francis, Golub, Lorne M., Zhang, Yu, Ojima, Iwao, Shroyer, Kenneth R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782470/ https://www.ncbi.nlm.nih.gov/pubmed/24086245 http://dx.doi.org/10.1371/journal.pone.0069884 |
Ejemplares similares
-
New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells
por: Botchkina, Galina I, et al.
Publicado: (2010) -
Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells
por: Rowehl, Rebecca A., et al.
Publicado: (2014) -
Quest for Efficacious Next-Generation Taxoid Anticancer
Agents and Their Tumor-Targeted Delivery
por: Ojima, Iwao, et al.
Publicado: (2018) -
Design, Synthesis, and Biological
Evaluations of Tumor-Targeting
Dual-Warhead Conjugates for a Taxoid–Camptothecin Combination
Chemotherapy
por: Vineberg, Jacob G., et al.
Publicado: (2014) -
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss
por: Bhatt, Heta Dinesh, et al.
Publicado: (2023)